David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Magnite
MGNI
$3.35B
| $840K | ﹤0.01% |
46,891
-261
| -0.6% | -$4.4K |
|
2677
PUT
Darden Restaurants
DRI
$24.8B
| $839K | ﹤0.01% |
13,536
| – | – |
|
2678
CALL
CNX Resources
CNX
$5.33B
| $837K | ﹤0.01% |
36,000
-12,000
| -25% | -$306K |
|
2679
CALL
Eagle Materials
EXP
$6.14B
| $836K | ﹤0.01% |
10,000
-30,000
| -75% | -$2.34M |
|
2680
Brunswick
BC
$5.16B
| $835K | ﹤0.01% |
16,228
+7,915
| +95% | +$420K |
|
2681
Talphera
TLPH
$65.4M
| $835K | ﹤0.01% |
10,808
-1,108
| -9% | -$145K |
|
2682
CALL
EQT Corp
EQT
$34.3B
| $829K | ﹤0.01% |
18,370
-18,370
| -50% | -$779K |
|
2683
CALL
NVIDIA
NVDA
$5.08T
| $827K | ﹤0.01% |
1,580,000
-2,908,000
| -65% | -$1.55M |
|
2684
CALL
Crown Castle
CCI
$32.1B
| $825K | ﹤0.01% |
10,000
-7,500
| -43% | -$639K |
|
|
2685
PUT
Crown Castle
CCI
$32.1B
| $825K | ﹤0.01% |
10,000
| – | – |
|
2686
PUT
Fossil Group
FOSL
$321M
| $825K | ﹤0.01% |
10,000
-10,000
| -50% | -$920K |
|
2687
Quanex
NX
$910M
| $823K | ﹤0.01% |
41,693
+1,536
| +4% | +$29.6K |
|
2688
PUT
Standex International
SXI
$3.7B
| $821K | ﹤0.01% |
+10,000
| New | +$741K |
|
2689
Accenture
ACN
$111B
| $820K | ﹤0.01% |
8,757
-38,388
| -81% | -$3.43M |
|
2690
PUT
Aflac
AFL
$58.9B
| $819K | ﹤0.01% |
25,600
| – | – |
|
|
JIVE
2691
DELISTED
Jive Software, Inc.
JIVE
| $818K | ﹤0.01% |
159,517
-187,234
| -54% | -$1.02M |
|
|
BNY
2692
CALL
Bank of New York Mellon
BNY
$111B
| $817K | ﹤0.01% |
20,300
-93,200
| -82% | -$3.63M |
|
|
TNAV
2693
DELISTED
Telenav Inc.
TNAV
| $817K | ﹤0.01% |
103,164
+49,038
| +91% | +$378K |
|
2694
PUT
Manitowoc
MTW
$701M
| $815K | ﹤0.01% |
41,730
-44,158
| -51% | -$828K |
|
|
BRSS
2695
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $815K | ﹤0.01% |
52,759
+37,764
| +252% | +$524K |
|
|
TLM
2696
DELISTED
TALISMAN ENERGY INC
TLM
| $815K | ﹤0.01% |
106,100
+34,200
| +48% | +$261K |
|
|
NEWP
2697
DELISTED
NEWPORT CORP
NEWP
| $814K | ﹤0.01% |
42,709
+15,208
| +55% | +$294K |
|
2698
CALL
Synaptics
SYNA
$3.74B
| $813K | ﹤0.01% |
10,000
-77,100
| -89% | -$5.82M |
|
|
HTLF
2699
DELISTED
Heartland Financial USA, Inc.
HTLF
| $813K | ﹤0.01% |
24,908
+13,299
| +115% | +$394K |
|
|
ACOR
2700
DELISTED
Acorda Therapeutics
ACOR
| $813K | ﹤0.01% |
204
+8
| +4% | +$36.6K |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.